[1]
N. Barabash and T. M. Tykhonova, “Experience with Dopamine Agonists in the Treatment of Prolactinomas”, AML, vol. 29, no. 2, pp. 311–317, Nov. 2022, doi: 10.15388/Amed.2022.29.2.15.